3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
31
Lung Neoplasms
11
Head and Neck Neoplasms
5
Breast Neoplasms
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma
2
Brain Neoplasms
2
Adenocarcinoma Of Esophagus
2
Urinary Bladder Neoplasms
1
Untreated Childhood Anaplastic Astrocytoma
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Salivary Gland Neoplasms
1
Recurrence
1
Pleural Effusion, Malignant
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Interventions
Temozolomide
4
Capecitabine
4
Bevacizumab
3
Leucovorin
2
Fluorouracil
2
Everolimus
2
temsirolimus
1
sapanisertib
1
regorafenib
1
pentetreotide
1
pazopanib
1
motesanib diphosphate
1
irinotecan sucrosofate
1
gallium Ga 68 dotatate
1
dehydroftorafur
1
batifiban
1
aflibercept
1
Sunitinib
1
Sorafenib
1
Sirolimus
1
Panobinostat
1
Oxaliplatin
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Fentanyl
1
Etoposide
1
Doxorubicin
1
Disulfides
1
Cytidine Triphosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Somatostatinoma
×
Gefitinib
×
Clear all
No trials found.